Immunomodulatory Drug CC-4047 is a Cell-type and Stimulus-Selective Transcriptional Inhibitor of Cyclooxygenase 2Gregory D. Ferguson, Kyle Chan, Laura G. Corral et al.|Journal of Clinical Immunology|2007Cited by 32
Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.Laure Moutouh de Parseval, Kyle Chan, Helen Brady et al.|Blood|2005Cited by 3
Lenalidomide and CC-4047 Inhibit the Proliferation of Namalwa Cancer Cells While Expanding CD34+ Progenitor Cells. New Insights on the Combination Therapy with Certain HDAC Inhibitors for Hematological Cancers.Dominique Verhelle, Helen Brady, Gregory D. Ferguson et al.|Blood|2006Cited by 0